Sandoz Group AG (SDZ) - Net Assets
Based on the latest financial reports, Sandoz Group AG (SDZ) has net assets worth CHF8.82 Billion CHF as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF21.61 Billion) and total liabilities (CHF12.79 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CHF8.82 Billion |
| % of Total Assets | 40.82% |
| Annual Growth Rate | 4.57% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 4857814.19 |
Sandoz Group AG - Net Assets Trend (2020–2024)
This chart illustrates how Sandoz Group AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Sandoz Group AG (2020–2024)
The table below shows the annual net assets of Sandoz Group AG from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CHF8.16 Billion | -5.66% |
| 2023-12-31 | CHF8.65 Billion | +11218609.08% |
| 2022-12-31 | CHF77.14K | -100.00% |
| 2021-12-31 | CHF7.44 Billion | +8.95% |
| 2020-12-31 | CHF6.83 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Sandoz Group AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 18.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CHF7.91 Billion | 96.88% |
| Common Stock | CHF25.00 Million | 0.31% |
| Other Comprehensive Income | CHF231.00 Million | 2.83% |
| Total Equity | CHF8.16 Billion | 100.00% |
Sandoz Group AG Competitors by Market Cap
The table below lists competitors of Sandoz Group AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xylem Inc
NYSE:XYL
|
$29.49 Billion |
|
Bajaj Auto Limited
NSE:BAJAJ-AUTO
|
$29.52 Billion |
|
Asia Vital Components Co Ltd
TW:3017
|
$29.54 Billion |
|
Hewlett Packard Enterprise Co
NYSE:HPE
|
$29.59 Billion |
|
Bharat Electronics Limited
NSE:BEL_old
|
$29.41 Billion |
|
Cognizant Technology Solutions Corp Class A
NASDAQ:CTSH
|
$29.36 Billion |
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
$29.34 Billion |
|
Expedia Group Inc.
NASDAQ:EXPE
|
$29.30 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Sandoz Group AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,276,064,250 to 8,163,000,000, a change of 886,935,750 (12.2%).
- Net income of 1,000,000 contributed positively to equity growth.
- Dividend payments of 215,000,000 reduced retained earnings.
- Share repurchases of 12,000,000 reduced equity.
- Other comprehensive income decreased equity by 242,848,950.
- Other factors increased equity by 1,355,784,700.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CHF1.00 Million | +0.01% |
| Dividends Paid | CHF215.00 Million | -2.63% |
| Share Repurchases | CHF12.00 Million | -0.15% |
| Other Comprehensive Income | CHF-242.85 Million | -2.97% |
| Other Changes | CHF1.36 Billion | +16.61% |
| Total Change | CHF- | 12.19% |
Book Value vs Market Value Analysis
This analysis compares Sandoz Group AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.57x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 4.24x to 3.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CHF15.82 | CHF67.16 | x |
| 2021-12-31 | CHF17.24 | CHF67.16 | x |
| 2022-12-31 | CHF0.00 | CHF67.16 | x |
| 2023-12-31 | CHF16.87 | CHF67.16 | x |
| 2024-12-31 | CHF18.81 | CHF67.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Sandoz Group AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.01%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 2.44x
- Recent ROE (0.01%) is above the historical average (-2.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 6.00% | 4.78% | 0.54x | 2.33x | CHF-272.95 Million |
| 2021 | 11.15% | 9.38% | 0.55x | 2.15x | CHF85.51 Million |
| 2022 | -29.64% | 0.00% | 88591.84x | 1.30x | CHF-30.57K |
| 2023 | 1.06% | 0.77% | 0.51x | 2.67x | CHF-650.61 Million |
| 2024 | 0.01% | 0.01% | 0.46x | 2.44x | CHF-815.30 Million |
Industry Comparison
This section compares Sandoz Group AG's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $249,566,333
- Average return on equity (ROE) among peers: -6.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Sandoz Group AG (SDZ) | CHF8.82 Billion | 6.00% | 1.45x | $29.43 Billion |
| CURATIS N AG (CURN) | $5.04 Million | -20.15% | 0.41x | $89.64 Million |
| PolyPeptide Group AG (PPGN) | $381.23 Million | -13.49% | 0.81x | $810.06 Million |
| Siegfried Holding Ltd (SFZN) | $362.43 Million | 14.86% | 0.48x | $3.71 Billion |
About Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage f… Read more